Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2209 ARTÍCULOS , VIENDO DEL 901 AL 915

Brain ischemia activates β- and γ-secretase cleavage of amyloid precursor protein: significance in sporadic Alzheimer's disease

Pluta R, Furmaga-Jabłońska W, Maciejewski R, Ułamek-Kozioł M, Jabłoński M.

Mol Neurobiol. 2013 Feb;47(1):425-34. doi: 10.1007/s12035-012-8360-z. Epub 2012 Oct 19.

The capillary dysfunction hypothesis of Alzheimer's disease

Østergaard L, Aamand R, Gutiérrez-Jiménez E, Ho YC, Blicher JU, Madsen SM, Nagenthiraja K, Dalby RB, Drasbek KR, Møller A, Brændgaard H, Mouridsen K, Jespersen SN, Jensen MS, West MJ.

Neurobiol Aging. 2013 Apr;34(4):1018-31. doi: 10.1016/j.neurobiolaging.2012.09.011. Epub 2012 Oct 18.

Astrocyte signaling and neurodegeneration: new insights into CNS disorders

Brambilla L, Martorana F, Rossi D.

Prion. 2013 Jan-Feb;7(1):28-36. doi: 10.4161/pri.22512. Epub 2012 Oct 23.

Alzheimer's disease: an update of the roles of receptors, astrocytes and primary cilia (review)

Armato U, Chakravarthy B, Pacchiana R, Whitfield JF.

Int J Mol Med. 2013 Jan;31(1):3-10. doi: 10.3892/ijmm.2012.1162. Epub 2012 Oct 24.

A direct morphometric comparison of five labeling protocols for multi-atlas driven automatic segmentation of the hippocampus in Alzheimer's disease

Nestor SM, Gibson E, Gao FQ, Kiss A, Black SE; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2013 Feb 1;66:50-70. doi: 10.1016/j.neuroimage.2012.10.081. Epub 2012 Nov 7.

A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse)

Chen Y, Liang Z, Blanchard J, Dai CL, Sun S, Lee MH, Grundke-Iqbal I, Iqbal K, Liu F, Gong CX.

Mol Neurobiol. 2013 Apr;47(2):711-25. doi: 10.1007/s12035-012-8375-5. Epub 2012 Nov 14.

Variant TREM2 as risk factor for Alzheimer's disease

Neumann H, Daly MJ.

N Engl J Med. 2013 Jan 10;368(2):182-4. doi: 10.1056/NEJMe1213157. Epub 2012 Nov 14.

Intracerebral propagation of Alzheimer's disease: strengthening evidence of a herpes simplex virus etiology

Ball MJ, Lukiw WJ, Kammerman EM, Hill JM.

Alzheimers Dement. 2013 Mar;9(2):169-75. doi: 10.1016/j.jalz.2012.07.005. Epub 2012 Nov 14.

APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease

Wolf AB, Caselli RJ, Reiman EM, Valla J.

Neurobiol Aging. 2013 Apr;34(4):1007-17. doi: 10.1016/j.neurobiolaging.2012.10.011. Epub 2012 Nov 16.

Prions, prionoids and pathogenic proteins in Alzheimer disease

Ashe KH, Aguzzi A.

Prion. 2013 Jan-Feb;7(1):55-9. doi: 10.4161/pri.23061. Epub 2012 Dec 3.

A case of atypical early-onset Alzheimer's disease carrying the missense mutation Thr354Ile in exon 10 of the PSEN1 gene

Marini S, Lucidi G, Tedde A, Bessi V, Nacmias B.

Neurol Sci. 2013 Sep;34(9):1691-2. doi: 10.1007/s10072-012-1260-1. Epub 2012 Dec 2.

Mitochondrial DNA oxidative damage and repair in aging and Alzheimer's disease

Santos RX, Correia SC, Zhu X, Smith MA, Moreira PI, Castellani RJ, Nunomura A, Perry G.

Antioxid Redox Signal. 2013 Jun 20;18(18):2444-57. doi: 10.1089/ars.2012.5039. Epub 2012 Dec 7.

Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controls

Esparza TJ, Zhao H, Cirrito JR, Cairns NJ, Bateman RJ, Holtzman DM, Brody DL.

Ann Neurol. 2013 Jan;73(1):104-19. doi: 10.1002/ana.23748. Epub 2012 Dec 7.

A presenilin 1 mutation in the first case of Alzheimer's disease

Müller U, Winter P, Graeber MB.

Lancet Neurol. 2013 Feb;12(2):129-30. doi: 10.1016/S1474-4422(12)70307-1. Epub 2012 Dec 14.

In vivo detection of cerebral cortical microinfarcts with high-resolution 7T MRI

van Veluw SJ, Zwanenburg JJ, Engelen-Lee J, Spliet WG, Hendrikse J, Luijten PR, Biessels GJ.

J Cereb Blood Flow Metab. 2013 Mar;33(3):322-9. doi: 10.1038/jcbfm.2012.196. Epub 2012 Dec 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias